Billiontoone Inc (BLLN)

$100.03 -8.91 (-8.18%)
Market Cap N/A
Revenue (ttm) 152.58M
Net Income (ttm) -41.57M
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin -27.24%
Debt to Equity Ratio N/A
Volume 461,700
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K N/A
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

BillionToOne, Inc., a precision diagnostics company, quantifies biology to create molecular diagnostics. The company provides molecular counting platform, which is designed to detect and measure DNA molecules at the single-count level to help enhance disease detection. It also offers UNITY Complete, a non-invasive prenatal screen that assesses fetal risk for aneuploidies, recessive conditions, and fetal antigens from a maternal blood draw; Northstar Select, a liquid biopsy test that provides a l...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 650 460 2551
Address:
1035 O’Brien Drive, Menlo Park, United States
Neeter
Neeter Aug. 3 at 10:44 PM
$BLLN looking for an excellent ER 8/5. Great looking chart. On IBDs best 50 & IPO lists.
0 · Reply
Bazziggr
Bazziggr Aug. 3 at 5:41 PM
$BLLN
0 · Reply
drew64
drew64 Aug. 1 at 5:36 PM
$BLLN Only 253 watchers; could be a hidden gem here😎🍻🤙🏼
0 · Reply
Neeter
Neeter Jul. 30 at 11:50 PM
$BLLN still my best performer and an unnoticed gem!
1 · Reply
Neeter
Neeter Jul. 29 at 2:12 AM
$BLLN My best performer. Expecting a great ER on 8/5
0 · Reply
Bazziggr
Bazziggr Jul. 22 at 1:44 PM
$BLLN back to $60?
1 · Reply
Neeter
Neeter Jul. 22 at 1:34 AM
$BLLN Rollin! On IBD's top 50.
0 · Reply
Bazziggr
Bazziggr Jul. 20 at 2:44 PM
$BLLN as expected
1 · Reply
Bazziggr
Bazziggr Jul. 17 at 12:23 PM
$BLLN meme junk
1 · Reply
trumpdisasterprez
trumpdisasterprez Jul. 15 at 7:47 PM
$SPCX $BLLN
0 · Reply
Latest News on BLLN
BillionToOne appoints Ethan Dmitrovsky as Chief Medical Officer

2026-07-20T13:06:06.000Z - 14 days ago

BillionToOne appoints Ethan Dmitrovsky as Chief Medical Officer

BillionToOne Appoints Ethan Dmitrovsky, MD, as Chief Medical Officer, Oncology, to Lead Medical Strategy for Northstar

Jul 20, 2026, 9:00 AM EDT - 14 days ago

BillionToOne Appoints Ethan Dmitrovsky, MD, as Chief Medical Officer, Oncology, to Lead Medical Strategy for Northstar

BillionToOne to Report Second Quarter 2026 Financial Results on August 5, 2026

Jul 15, 2026, 8:05 AM EDT - 19 days ago

BillionToOne to Report Second Quarter 2026 Financial Results on August 5, 2026

BillionToOne's Northstar Response® Is a Stronger Predictor of Immunotherapy Outcomes Than Standard-of-Care Imaging for Cancer Patients in Peer-Reviewed Study

Jun 29, 2026, 12:39 PM EDT - 5 weeks ago

BillionToOne's Northstar Response® Is a Stronger Predictor of Immunotherapy Outcomes Than Standard-of-Care Imaging for Cancer Patients in Peer-Reviewed Study

BillionToOne price target raised to $125 from $120 at Guggenheim

2026-06-29T11:00:13.000Z - 5 weeks ago

BillionToOne price target raised to $125 from $120 at Guggenheim

BillionToOne Transcript: AGM 2026

Jun 10, 2026, 12:00 PM EDT - 7 weeks ago

BillionToOne Transcript: AGM 2026

BillionToOne Transcript: 46th Annual William Blair Growth Stock Conference

Jun 2, 2026, 1:40 PM EDT - 2 months ago

BillionToOne Transcript: 46th Annual William Blair Growth Stock Conference

BillionToOne to Participate in the William Blair 46th Annual Growth Stock Conference

May 27, 2026, 4:05 PM EDT - 2 months ago

BillionToOne to Participate in the William Blair 46th Annual Growth Stock Conference

BillionToOne price target raised to $120 from $100 at Guggenheim

2026-05-13T11:22:07.000Z - 2 months ago

BillionToOne price target raised to $120 from $100 at Guggenheim

BillionToOne price target raised to $125 from $120 at JPMorgan

2026-05-07T15:38:45.000Z - 3 months ago

BillionToOne price target raised to $125 from $120 at JPMorgan

BillionToOne price target lowered to $130 from $140 at BTIG

2026-05-07T13:20:23.000Z - 3 months ago

BillionToOne price target lowered to $130 from $140 at BTIG

BillionToOne sees FY26 revenue $450M-$465M, consensus $437.6M

2026-05-07T00:59:44.000Z - 3 months ago

BillionToOne sees FY26 revenue $450M-$465M, consensus $437.6M

BillionToOne reports Q1 EPS 34c, consensus 4c

2026-05-07T00:59:19.000Z - 3 months ago

BillionToOne reports Q1 EPS 34c, consensus 4c

BillionToOne Earnings Call Transcript: Q1 2026

May 6, 2026, 4:30 PM EDT - 3 months ago

BillionToOne Earnings Call Transcript: Q1 2026

BillionToOne Slides: Q1 2026

May 6, 2026, 4:30 PM EDT - 3 months ago

BillionToOne Slides: Q1 2026

BillionToOne Earnings release: Q1 2026

May 6, 2026, 4:30 PM EDT - 3 months ago

BillionToOne Earnings release: Q1 2026

BillionToOne Quarterly report: Q1 2026

May 6, 2026, 4:30 PM EDT - 3 months ago

BillionToOne Quarterly report: Q1 2026

BillionToOne Reports First Quarter 2026 Results and Raises 2026 Revenue Guidance

May 6, 2026, 4:05 PM EDT - 3 months ago

BillionToOne Reports First Quarter 2026 Results and Raises 2026 Revenue Guidance

BillionToOne Launches Unity Confirm™: A category-defining test that bridges the gap between screening and invasive diagnostics

May 1, 2026, 7:00 PM EDT - 3 months ago

BillionToOne Launches Unity Confirm™: A category-defining test that bridges the gap between screening and invasive diagnostics

BillionToOne Proxy statement: Proxy filing

Apr 21, 2026, 8:00 AM EDT - 3 months ago

BillionToOne Proxy statement: Proxy filing

BillionToOne Proxy statement: Proxy filing

Apr 21, 2026, 8:00 AM EDT - 3 months ago

BillionToOne Proxy statement: Proxy filing

BillionToOne Appoints Dr. Allen Chen as Vice President of Medical Affairs and Clinical Development, Oncology

Apr 2, 2026, 9:00 AM EDT - 4 months ago

BillionToOne Appoints Dr. Allen Chen as Vice President of Medical Affairs and Clinical Development, Oncology

BillionToOne price target lowered to $100 from $120 at Guggenheim

2026-03-30T11:55:33.000Z - 4 months ago

BillionToOne price target lowered to $100 from $120 at Guggenheim

BillionToOne price target lowered to $140 from $160 at BTIG

2026-03-05T12:50:24.000Z - 5 months ago

BillionToOne price target lowered to $140 from $160 at BTIG

BillionToOne price target lowered to $140 from $160 at BTIG

2026-03-05T12:28:04.000Z - 5 months ago

BillionToOne price target lowered to $140 from $160 at BTIG

BillionToOne price target lowered to $90 from $110 at Wells Fargo

2026-03-05T11:20:34.000Z - 5 months ago

BillionToOne price target lowered to $90 from $110 at Wells Fargo

BillionToOne reports Q4 EPS 11c, consensus 17c

2026-03-04T21:42:49.000Z - 5 months ago

BillionToOne reports Q4 EPS 11c, consensus 17c

BillionToOne raises FY26 revenue view to $430M-$445M from $415M-$430M

2026-03-04T21:40:40.000Z - 5 months ago

BillionToOne raises FY26 revenue view to $430M-$445M from $415M-$430M

BillionToOne Earnings Call Transcript: Q4 2025

Mar 4, 2026, 4:30 PM EST - 5 months ago

BillionToOne Earnings Call Transcript: Q4 2025

BillionToOne Annual report: Q4 2025

Mar 4, 2026, 4:30 PM EST - 5 months ago

BillionToOne Annual report: Q4 2025

BillionToOne Earnings release: Q4 2025

Mar 4, 2026, 4:30 PM EST - 5 months ago

BillionToOne Earnings release: Q4 2025

BillionToOne Slides: Q4 2025

Mar 4, 2026, 4:30 PM EST - 5 months ago

BillionToOne Slides: Q4 2025

BillionToOne Reports Fourth Quarter and Full Year 2025 Results and Raises 2026 Revenue Guidance

Mar 4, 2026, 4:05 PM EST - 5 months ago

BillionToOne Reports Fourth Quarter and Full Year 2025 Results and Raises 2026 Revenue Guidance

BillionToOne to Report Fourth Quarter and Full Year 2025 Financial Results on March 4, 2026

Feb 17, 2026, 8:05 AM EST - 5 months ago

BillionToOne to Report Fourth Quarter and Full Year 2025 Financial Results on March 4, 2026

BillionToOne Expands Northstar Platform with Launch of Two New Add-On Liquid Biopsy Applications for Northstar Select®

Feb 10, 2026, 9:00 AM EST - 6 months ago

BillionToOne Expands Northstar Platform with Launch of Two New Add-On Liquid Biopsy Applications for Northstar Select®

BillionToOne Announces Dual Launch of UNITY Expanded Red Blood Cell and Platelet Fetal Antigen NIPTs, Extending Its Leadership In Setting the New Standard in Prenatal Care

Feb 9, 2026, 12:29 PM EST - 6 months ago

BillionToOne Announces Dual Launch of UNITY Expanded Red Blood Cell and Platelet Fetal Antigen NIPTs, Extending Its Leadership In Setting the New Standard in Prenatal Care

BillionToOne collaborating with Epic for prenatal and oncology testing

2026-01-15T14:06:28.000Z - 7 months ago

BillionToOne collaborating with Epic for prenatal and oncology testing

BillionToOne Announces Collaboration with Epic to Expand Prenatal and Oncology Testing Across Healthcare

Jan 15, 2026, 8:58 AM EST - 7 months ago

BillionToOne Announces Collaboration with Epic to Expand Prenatal and Oncology Testing Across Healthcare

BillionToOne Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 12, 2026, 12:45 PM EST - 7 months ago

BillionToOne Transcript: 44th Annual J.P. Morgan Healthcare Conference

BillionToOne Slides: 44th Annual J.P. Morgan Healthcare Conference

Jan 12, 2026, 12:45 PM EST - 7 months ago

BillionToOne Slides: 44th Annual J.P. Morgan Healthcare Conference

BillionToOne sees FY26 revenue $415M-$430M, consensus $393.61M

2026-01-12T13:15:47.000Z - 7 months ago

BillionToOne sees FY26 revenue $415M-$430M, consensus $393.61M

BillionToOne Provides Guidance for 2026

Jan 12, 2026, 8:05 AM EST - 7 months ago

BillionToOne Provides Guidance for 2026

BillionToOne management to meet with BTIG

2026-01-07T17:30:14.000Z - 7 months ago

BillionToOne management to meet with BTIG

BillionToOne Announces Selection of Northstar Select® as the new liquid biopsy test for LC-SCRUM-TRY clinical study at National Cancer Center Hospital East

Jan 6, 2026, 9:00 AM EST - 7 months ago

BillionToOne Announces Selection of Northstar Select® as the new liquid biopsy test for LC-SCRUM-TRY clinical study at National Cancer Center Hospital East

BillionToOne initiated with a Buy at Guggenheim

2026-01-06T11:52:55.000Z - 7 months ago

BillionToOne initiated with a Buy at Guggenheim

BillionToOne falls -5.5%

2025-12-24T17:05:50.000Z - 7 months ago

BillionToOne falls -5.5%

BillionToOne to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Dec 23, 2025, 8:05 AM EST - 7 months ago

BillionToOne to Participate in the 44th Annual J.P. Morgan Healthcare Conference

BillionToOne Earnings Call Transcript: Q3 2025

Dec 9, 2025, 4:30 PM EST - 8 months ago

BillionToOne Earnings Call Transcript: Q3 2025

BillionToOne Quarterly report: Q3 2025

Dec 9, 2025, 4:30 PM EST - 8 months ago

BillionToOne Quarterly report: Q3 2025

BillionToOne Earnings release: Q3 2025

Dec 9, 2025, 4:30 PM EST - 8 months ago

BillionToOne Earnings release: Q3 2025

BillionToOne Slides: Q3 2025

Dec 9, 2025, 4:30 PM EST - 8 months ago

BillionToOne Slides: Q3 2025

BillionToOne Appoints Anthony Pagano to Board of Directors as Audit Committee Chair

Dec 9, 2025, 4:07 PM EST - 8 months ago

BillionToOne Appoints Anthony Pagano to Board of Directors as Audit Committee Chair

BillionToOne Reports Third Quarter 2025 Results

Dec 9, 2025, 4:05 PM EST - 8 months ago

BillionToOne Reports Third Quarter 2025 Results

BillionToOne to Report Third Quarter 2025 Financial Results on December 9, 2025

Dec 2, 2025, 8:05 AM EST - 8 months ago

BillionToOne to Report Third Quarter 2025 Financial Results on December 9, 2025

BillionToOne wins upbeat coverage as analysts flag growth in prenatal, cancer tests

Dec 1, 2025, 6:49 AM EST - 8 months ago

BillionToOne wins upbeat coverage as analysts flag growth in prenatal, cancer tests

Gunderson Dettmer Represents Long-Time Client BillionToOne in its Upsized $273.1 Million Initial Public Offering

Nov 6, 2025, 5:02 PM EST - 9 months ago

Gunderson Dettmer Represents Long-Time Client BillionToOne in its Upsized $273.1 Million Initial Public Offering

BillionToOne valued at $4.4 billion as shares surge in blockbuster Nasdaq debut

Nov 6, 2025, 12:44 PM EST - 9 months ago

BillionToOne valued at $4.4 billion as shares surge in blockbuster Nasdaq debut

Molecular diagnostics firm BillionToOne raises $273 million in US IPO

Nov 5, 2025, 10:36 PM EST - 9 months ago

Molecular diagnostics firm BillionToOne raises $273 million in US IPO

BillionToOne Announces Pricing of Upsized Initial Public Offering

Nov 5, 2025, 9:53 PM EST - 9 months ago

BillionToOne Announces Pricing of Upsized Initial Public Offering

BillionToOne Announces Launch of Initial Public Offering Roadshow

Oct 29, 2025, 6:00 AM EDT - 9 months ago

BillionToOne Announces Launch of Initial Public Offering Roadshow

BillionToOne targets over $2 billion valuation in US IPO

Oct 17, 2025, 6:09 PM EDT - 10 months ago

BillionToOne targets over $2 billion valuation in US IPO

BillionToOne Registration statement: Registration Filing

Oct 17, 2025, 8:00 AM EDT - 10 months ago

BillionToOne Registration statement: Registration Filing

Molecular diagnostics firm BillionToOne files for US IPO

Oct 7, 2025, 6:17 PM EDT - 10 months ago

Molecular diagnostics firm BillionToOne files for US IPO

Neeter
Neeter Aug. 3 at 10:44 PM
$BLLN looking for an excellent ER 8/5. Great looking chart. On IBDs best 50 & IPO lists.
0 · Reply
Bazziggr
Bazziggr Aug. 3 at 5:41 PM
$BLLN
0 · Reply
drew64
drew64 Aug. 1 at 5:36 PM
$BLLN Only 253 watchers; could be a hidden gem here😎🍻🤙🏼
0 · Reply
Neeter
Neeter Jul. 30 at 11:50 PM
$BLLN still my best performer and an unnoticed gem!
1 · Reply
Neeter
Neeter Jul. 29 at 2:12 AM
$BLLN My best performer. Expecting a great ER on 8/5
0 · Reply
Bazziggr
Bazziggr Jul. 22 at 1:44 PM
$BLLN back to $60?
1 · Reply
Neeter
Neeter Jul. 22 at 1:34 AM
$BLLN Rollin! On IBD's top 50.
0 · Reply
Bazziggr
Bazziggr Jul. 20 at 2:44 PM
$BLLN as expected
1 · Reply
Bazziggr
Bazziggr Jul. 17 at 12:23 PM
$BLLN meme junk
1 · Reply
trumpdisasterprez
trumpdisasterprez Jul. 15 at 7:47 PM
$SPCX $BLLN
0 · Reply
Annie_Preferred
Annie_Preferred Jul. 15 at 7:46 PM
$SPCX should come back like $BLLN ... these things snap back like a mouse trap!
0 · Reply
redbullnweed
redbullnweed Jul. 9 at 7:53 PM
$BLLN Lots of people sleeping on this. I guess they hate money.
1 · Reply
JodieChristy
JodieChristy Jul. 6 at 6:49 PM
Past picks $NVAN and $BLLN both performed exceptionally well. $IBM was the top setup for this week, but it already gapped up significantly. Looking for a new setup by EOD.
0 · Reply
JFDI
JFDI Jun. 29 at 1:41 PM
$BLLN ‘s baby
0 · Reply
Nosh
Nosh Jun. 29 at 2:14 AM
$BLLN 👀👀
0 · Reply
JFDI
JFDI Jun. 28 at 11:23 PM
@Doozio ... $BLLN ?
1 · Reply
Doozio
Doozio Jun. 28 at 9:08 PM
Now 🐑 are still SKWD of semis n tech pulling back went da huckleberries can turns $CENT s ONTA $BLLN s wen they go thru da $$$ ENTA 🐒🍌🧠⏰♾️
1 · Reply
CarterEllis
CarterEllis Jun. 24 at 4:49 PM
$BLLN wants to breakout but indices are doing sideways business. Patience is virtue!
0 · Reply
Bazziggr
Bazziggr Jun. 22 at 3:21 PM
$BLLN join with UTHR
0 · Reply
Doozio
Doozio Jun. 19 at 3:21 PM
N YO ain’t even made da $BLLN s yet ONTO 🐒🍌🧠⏰♾️
0 · Reply
redbullnweed
redbullnweed Jun. 18 at 8:46 PM
$BLLN thinking 120 EOY
1 · Reply
Albino_Trader123
Albino_Trader123 Jun. 18 at 6:13 PM
$BLLN New ipo with good rev growth. Looking nice here
0 · Reply